News
Biotech cools off in August as capital markets weaken September 01, 2010 | Press Release
Biotech gets hot in July August 02, 2010 | Press Release
Shawn Cross appointed CEO of Burrill Merchant Banking Group July 28, 2010 | Press Release
See all News
Burrill Merchant Banking provides a broad and complementary range of services to address the needs of our clients at various stages in their growth. These include the ability to identify and acquire strategic assets and capabilities; identify and partner with companies who will share the risk and rewards of developing an asset; monetize non-strategic assets through divestiture; and access capital through a variety of mechanisms.Burrill Merchant Banking experience covers a wide range within life sciences including biotechnology, pharmaceutical, diagnostics, drug discovery and enabling technologies, medical devices, agricultural
biotechnology and nutraceuticals.

